Science on FDA Liberalization: A Response to the Status Quo Process for Medical Treatments
A Modern System for Approving the Cures of The Future
How Extending The AIDS Drug Access Model to Other Diseases Would Save Lives
Free To Choose Medicine in Japan: A Model for America
An early version of FTCM was distributed in a Japanese booklet and played a role in Japan’s passage of legislation in 2013 that implemented FTCM principles for regenerative medicine drugs. A Forbes op-ed (December 1, 2015) with the economist Vernon Smith, “Give the FDA Some Competition with Free To Choose Medicine,” click here, highlights the benefits from FTCM and the importance of Japan’s market-based approach. For more information on this topic, click here.